Perioperative and pathologic outcomes divided by surgical approaches.
Variables
Anterior approach (n = 135)
Transvesical approach (n = 73)
Posterior approach (n = 66)
Operative time, min, mean (SD)
117.7 (25.0)
133.3 (27.7)
128.4 (29.0)
0.001
Estimated blood loss, mL, mean (SD)
98.6 (48.5)
111.9 (62.8)
105.5 (75.7)
0.247
ePLND, n (%)
37 (27.4%)
8 (11.0%)
6 (9.1%)
0.001
Open conversion, n (%)
0 (0%)
0 (0%)
0 (0%)
—
Transfusion, n (%)
5 (3.7%)
1 (1.4%)
3 (4.5%)
0.561
Nerve-sparing technique, n (%)
92 (68.1%)
69 (94.5%)
61 (92.4%)
0.001
Postoperative pathology
Pathological T stage, n (%)
0.001
pT2
91 (67.4%)
63 (86.3%)
59 (89.4%)
pT3
44 (32.6%)
10 (13.7%)
7 (10.6%)
Specimen Gleason score, median (IQR)
7 (5.8)
6 (5.7)
7 (5.7)
0.038
Positive surgical margin, n (%)
25 (18.5%)
11 (15.1%)
9 (13.6%)
0.637
Positive lymph node, n (%)
12 (8.9%)
3 (4.1%)
3 (4.5%)
0.389
ePLND: extended pelvic lymph nodes dissection; SD: standard deviation; IQR: interquartile range. †Continuous variables were compared using the Kruskal–Wallis test, and categorical variables were compared using the Chi-square test.
